A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia

被引：1
|
作者：
Shah, Bijal D. [1 ]
Rozario, Nicole [2 ]
Turba, Elyce P. [3 ]
Bello, Celeste [4 ]
Chavez, Julio C. [3 ]
Sokol, Lubomir [4 ]
Brayer, Jason [5 ]
Lancet, Jeffrey E. [6 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151936
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4399
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Jaktinib in patients (pts) with myelofibrosis (MF) who were refractory to or relapsed after ruxolitinib: A single-arm, open-label, multicenter, phase 2 study
    Jin, Jie
    Zhang, Yi
    Zhang, Qike
    Liu, Qingchi
    Zhou, Hu
    Gao, Sujun
    Wang, Wei
    Dang, Huibing
    Chen, Yuqing
    Wang, Jishi
    Zhao, Peng
    Yang, Haiping
    Ma, Liangming
    Zhao, Qingwei
    Suo, Shanshan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
    Cortes, Jorge
    Perl, Alexander E.
    Dohner, Hartmut
    Kantarjian, Hagop
    Martinelli, Giovanni
    Kovacsovics, Tibor
    Rousselot, Philippe
    Steffen, Bjorn
    Dombret, Herve
    Estey, Elihu
    Strickland, Stephen
    Altman, Jessica K.
    Baldus, Claudia D.
    Burnett, Alan
    Kramer, Alwin
    Russell, Nigel
    Shah, Neil P.
    Smith, Catherine C.
    Wang, Eunice S.
    Ifrah, Norbert
    Gammon, Guy
    Trone, Denise
    Lazzaretto, Deborah
    Levis, Mark
    LANCET ONCOLOGY, 2018, 19 (07): : 889 - 903
  • [43] UCHMC 1812: A phase 1b trial of CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myeloid leukemia.
    Gaut, Daria Louise
    Callas, Bradley
    Damon, Lloyd Earl
    Jonas, Brian Andrew
    Jeyakumar, Deepa
    Borror, Catherine
    Osorio, Stephanie
    Ta, Teresa
    Park, Sunmin
    Schiller, Gary J.
    Wieduwilt, Matthew Joseph
    Oliai, Caspian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Selinexor and Chidamide in Patients with Relapsed/Refractory Acute Myeloid Leukemia Exposed to Venetoclax: A Single-Arm, Phase 2 Study
    Zhang, Jian
    Song, Baoquan
    Liu, Yin
    Wu, Yanjun
    Wu, De-Pei
    Qiu, Huiying
    BLOOD, 2023, 142
  • [45] An open-label, single-arm phase II study of everolimus (RAD001) in patients with relapsed/refractory classical Hodgkin lymphoma (HL)
    Johnston, P. B.
    Lewis, L. T.
    Rogerio, J. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Once-weekly ofatumumab in untreated or relapsed Waldenstrom's macroglobulinaemia: an open-label, single-arm, phase 2 study
    Furman, Richard R.
    Eradat, Herbert A.
    DiRienzo, Christine G.
    Hofmeister, Craig C.
    Hayman, Suzanne R.
    Leonard, John P.
    Coleman, Morton
    Advani, Ranjana
    Chanan-Khan, Asher
    Switzky, Julie
    Liao, Qiming M.
    Shah, Damini
    Jewell, Roxanne C.
    Lisby, Steen
    Lin, Thomas S.
    LANCET HAEMATOLOGY, 2017, 4 (01): : E24 - E34
  • [47] Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
    Patrick K. Reville
    Hagop M. Kantarjian
    Farhad Ravandi
    Elias Jabbour
    Courtney D. DiNardo
    Naval Daver
    Naveen Pemmaraju
    Maro Ohanian
    Yesid Alvarado
    Lianchun Xiao
    Gheath Alatrash
    Sanam Loghavi
    Caitlin R. Rausch
    Gautam Borthakur
    Marina Konopleva
    Jorge Cortes
    Tapan M. Kadia
    Blood Cancer Journal, 11
  • [48] Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
    Reville, Patrick K.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Jabbour, Elias
    DiNardo, Courtney D.
    Daver, Naval
    Pemmaraju, Naveen
    Ohanian, Maro
    Alvarado, Yesid
    Xiao, Lianchun
    Alatrash, Gheath
    Loghavi, Sanam
    Rausch, Caitlin R.
    Borthakur, Gautam
    Konopleva, Marina
    Cortes, Jorge
    Kadia, Tapan M.
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [49] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
    Agulnik, Mark
    Schulte, Brian
    Robinson, Steven
    Hirbe, Angela C.
    Kozak, Kevin
    Chawla, Sant P.
    Attia, Steven
    Rademaker, Alfred
    Zhang, Hui
    Abbinanti, Susan
    Cehic, Rasima
    Monga, Varun
    Milhem, Mohammed
    Okuno, Scott
    Van Tine, Brian A.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208
  • [50] An open-label, single-arm pilot study of tocotrienols supplementation on improving memory and attention in healthy young adults
    Par, Rae Yi Xin
    Teo, Cheryl Wei Ling
    Tan, Javier Joon Kiat
    Ung, Yee Wei
    Heng, Kiang Soon
    Hang, Li Ting
    Yeo, Mervyn
    Yap, Wei Ney
    JOURNAL OF FUNCTIONAL FOODS, 2022, 92
12345